Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7

被引:32
|
作者
Renneboog, B
Hansen, V
Heimann, P
DeMulder, A
Janssen, F
Ferster, A
机构
[1] HOP UNIV ENFANTS REINE FABIOLA,HAEMATOONCOL UNIV,B-1020 BRUSSELS,BELGIUM
[2] HOP UNIV ENFANTS REINE FABIOLA,NEPHROL UNIT,B-1020 BRUSSELS,BELGIUM
[3] HOP BRUGMANN,LAB HAEMATOL & CYTOGENET,BRUSSELS,BELGIUM
关键词
t-MDS; myelodysplasia; monosomy; 7; azathioprine;
D O I
10.1046/j.1365-2141.1996.00400.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case of spontaneously reversible refractory anaemia, a subtype of myelodysplastic syndrome (MDS), with monosomy 7 secondary to chronic treatment with azathioprine (AZA) in a young renal transplant recipient, AZA was stopped after that conventional cytogenetics and fluorescence in situ hybridization (FISH) had demonstrated the existence of a monosomy 7 clone. 4 months later, haematological values had considerably improved and the karyotypic examination as well as the FISH analysis were normal. The spontaneous remission of this MDS with monosomy 7, which is usually associated with a particularly poor prognosis, could be due to the recovery of a better immunosurveillance following the withdrawal of AZA.
引用
收藏
页码:696 / 698
页数:3
相关论文
共 50 条
  • [41] Characteristics of patients with therapy-related myelodysplastic syndrome
    Belohlavkova, P.
    Voglova, J.
    Neuwirtova, R.
    Krejcova, H.
    Cermak, J.
    Vondrakova, J.
    Vozobulova, V.
    Krejci, M.
    Muzik, J.
    LEUKEMIA RESEARCH, 2009, 33 : S102 - S102
  • [42] Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone
    Lana Jajac Bručić
    Ivan Krečak
    Annals of Hematology, 2023, 102 : 499 - 500
  • [43] Myelodysplastic Syndrome with Monosomy 7 in a Patient with Ataxia-Pancytopenia Syndrome
    Wildes, T. J.
    Rentas, S.
    Carlsen, E.
    Dennison, J.
    Dixon, A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S100 - S100
  • [44] Therapy-related myelodysplastic syndrome with monosomy 7 and metastatic renal cell carcinoma successfully treated with nivolumab: two birds with one stone
    Brucic, Lana Jajac
    Krecak, Ivan
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 499 - 500
  • [46] Identifying Novel Genes and Signaling Pathways That Predispose to Therapy Related MDS (t-MDS)
    Akunuru, Shailaja
    Seymore, Kimberly
    Kumar, Rupali
    Nattamai, Kalpana
    Geiger, Hartmut
    BLOOD, 2014, 124 (21)
  • [47] Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS)
    Yarosh, Rina
    Roesler, Michelle A.
    Murray, Thomas
    Cioc, Adina
    Hirsch, Betsy
    Nguyen, Phuong
    Warlick, Erica
    Poynter, Jenny N.
    CANCER CAUSES & CONTROL, 2021, 32 (03) : 241 - 250
  • [48] Empty marrow following previous irradiation in a patient with therapy-related myelodysplastic syndrome
    Lee, Chun-Hui
    Chen, Tsai-Yun
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (05) : 703 - 703
  • [49] Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS)
    Rina Yarosh
    Michelle A. Roesler
    Thomas Murray
    Adina Cioc
    Betsy Hirsch
    Phuong Nguyen
    Erica Warlick
    Jenny N. Poynter
    Cancer Causes & Control, 2021, 32 : 241 - 250
  • [50] Treatment Related Myelodysplastic Syndromes (t-MDS) in Children with Cancer: A Single Center Experience
    Tragiannidis, A.
    Papageorgiou, M.
    Damianidou, L.
    Hatzipantelis, E.
    Papageorgiou, T.
    Hatzistilianou, M.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S191 - S191